Primary Hyperoxaluria

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

Baby Detect : Genomic Newborn Screening

Rare Kidney Stone Consortium Biobank

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

Rare Kidney Stone Consortium Patient Registry

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1

National Registry of Rare Kidney Diseases

Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

Health-related Quality of Life in Rare Kidney Stone

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis

A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Phenotyping of Primary Hyperoxaluria

Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia

Primary Hyperoxaluria Mutation Genotyping/Phenotyping

Primary Hyperoxaluria Mutation Genotyping

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria